236 related articles for article (PubMed ID: 30527378)
1. Nation-wide survey of advanced non-melanoma skin cancers treated at dermatology departments in Japan.
Fujisawa Y; Funakoshi T; Nakamura Y; Ishii M; Asai J; Shimauchi T; Fujii K; Fujimoto M; Katoh N; Ihn H
J Dermatol Sci; 2018 Dec; 92(3):230-236. PubMed ID: 30527378
[TBL] [Abstract][Full Text] [Related]
2. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
[TBL] [Abstract][Full Text] [Related]
3. Update on the Use and Treatment of Targeted Molecular Inhibitors for Locally Advanced and Metastatic Non-Melanoma Skin Cancers.
Odueyungbo M; Ratner D
Dermatol Surg; 2016 Jan; 42 Suppl 1():S49-56. PubMed ID: 26730974
[TBL] [Abstract][Full Text] [Related]
4. Skin cancers in Croatia, 2003-2005: epidemiological study.
Lipozencić J; Celić D; Strnad M; Toncić RJ; Pasić A; Rados J; Znaor A
Coll Antropol; 2010 Sep; 34(3):865-9. PubMed ID: 20977074
[TBL] [Abstract][Full Text] [Related]
5. Results of second-stage screening for skin cancers in Oita Prefecture, Japan.
Kai Y; Ishikawa K; Goto M; Sakai T; Ito A; Shono T; Shimada H; Shimizu F; Goto M; Hatano Y; Okamoto O; Katagiri K; Aono H; Eshima N; Fujiwara S
J Dermatol; 2015 Dec; 42(12):1160-4. PubMed ID: 26177589
[TBL] [Abstract][Full Text] [Related]
6. Update of cetuximab for non-melanoma skin cancer.
Wollina U
Expert Opin Biol Ther; 2014 Feb; 14(2):271-6. PubMed ID: 24387664
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of a history of skin cancer in 2007: results of an incidence-based model.
Stern RS
Arch Dermatol; 2010 Mar; 146(3):279-82. PubMed ID: 20231498
[TBL] [Abstract][Full Text] [Related]
8. Exploratory Assessment of Oxygen Flow-Assisted Cutaneous Administration of Methotrexate for Superficial Basal Cell Carcinoma, Mycosis Fungoides, and Extramammary Paget Disease.
Lebas E; Chapelier C; Quatresooz P; Seidel L; Nikkels AF
J Invest Dermatol; 2020 Mar; 140(3):583-592. PubMed ID: 31513804
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of low-dose 5-fluorouracil/cisplatin therapy for invasive extramammary Paget's disease.
Kato H; Watanabe S; Kariya K; Nakamura M; Morita A
J Dermatol; 2018 May; 45(5):560-563. PubMed ID: 29446148
[TBL] [Abstract][Full Text] [Related]
10. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
11. Skin cancer incidence among atomic bomb survivors from 1958 to 1996.
Sugiyama H; Misumi M; Kishikawa M; Iseki M; Yonehara S; Hayashi T; Soda M; Tokuoka S; Shimizu Y; Sakata R; Grant EJ; Kasagi F; Mabuchi K; Suyama A; Ozasa K
Radiat Res; 2014 May; 181(5):531-9. PubMed ID: 24754560
[TBL] [Abstract][Full Text] [Related]
12. Scrotal cancer survival is influenced by histology: a SEER study.
Johnson TV; Hsiao W; Delman KA; Canter DJ; Master VA
World J Urol; 2013 Jun; 31(3):585-90. PubMed ID: 22418823
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic treatment options for advanced epithelial skin cancer.
Soura E; Chasapi V; Stratigos AJ
Expert Opin Pharmacother; 2015; 16(10):1479-93. PubMed ID: 26027692
[TBL] [Abstract][Full Text] [Related]
14. Optimal treatment of unresectable nonmelanoma skin cancers.
Olencki T
J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):789-92. PubMed ID: 24853218
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of skin cancer based on Japan's National Cancer Registry 2016-2017.
Ogata D; Namikawa K; Nakano E; Fujimori M; Uchitomi Y; Higashi T; Yamazaki N; Kawai A
Cancer Sci; 2023 Jul; 114(7):2986-2992. PubMed ID: 37095610
[TBL] [Abstract][Full Text] [Related]
16. Combination of targeted therapy and immune checkpoint blocker in a patient with xeroderma pigmentosum presenting an aggressive angiosarcoma and a recurrent non-resectable basal cell carcinoma.
Boutros C; Rouleau E; Majer M; Nikolaev S; Robert C
Eur J Cancer; 2021 Jun; 150():130-132. PubMed ID: 33901791
[No Abstract] [Full Text] [Related]
17. Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients.
Funk-Debleds P; Ducroux E; Guillaud O; Ursic-Bedoya J; Decullier E; Vallin M; Euvrard S; Pageaux GP; Boillot O; Dumortier J
J Am Acad Dermatol; 2018 Jul; 79(1):84-91. PubMed ID: 29307647
[TBL] [Abstract][Full Text] [Related]
18. Non-melanoma skin cancer: new and future synthetic drug treatments.
Amaral T; Garbe C
Expert Opin Pharmacother; 2017 May; 18(7):689-699. PubMed ID: 28414587
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of skin cancers among adult patients in an urban Malaysian population.
Han WH; Yong SS; Tan LL; Toh YF; Chew MF; Pailoor J; Kwan Z
Australas J Dermatol; 2019 Nov; 60(4):e327-e329. PubMed ID: 31222718
[TBL] [Abstract][Full Text] [Related]
20. Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin Cancers.
Komatsubara KM; Jeter J; Carvajal RD; Margolin K; Schadendorf D; Hauschild A
Am Soc Clin Oncol Educ Book; 2017; 37():641-650. PubMed ID: 28561682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
